BioSpace News Archive

Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the appointment of Alex Martin as Chairman of the Board of Directors. Mr. Martin brings to the Chairman’s role over 25 years of experience in senior executive roles in the life sciences industry, with a focus on bus

Series A led by Canaan Partners, Samsara BioCapital and The Column Group Foundational research into cytokine structural biology and immune function licensed from Stanford University Nils Lonberg joins founding investors on board of directors

Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX:TBP.TO) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that Ms. Dale Weil and Dr. Brent Norton have been appointed to the Company’s Board of Directors and Dr. Graham Wood, Ph.D. has been appointed as Chief Operating Officer.

Proniras Corporation, a biotechnology company committed to the development of life saving therapeutic products, today announced that the company and its collaborator, Indiana University (IU) School of Medicine, have received a $12.3 million grant from the National Institute on Drug Abuse (NIDA) to support development of the company’s proprietary molecule, tezampanel, as a treatment for opioid withdrawal syndrome. Tezampanel, a

NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company accelerating the genetic revolution using a new class of synthetic medicines, today announced that Dietrich A. Stephan, Ph.D., chief executive officer, is scheduled to present at the Myotonic Dystrophy Foundation 2020 Virtual Conference on September 25 between 4:00 p.m. and 4:45 p.m. ET. The conference will be held virtually on September 25-26, 2020 a

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for people with central nervous system (CNS) disorders, today announced that it has expanded its leadership team as it works to advance its clinical and preclinical-stage portfolio of novel programs for both rare and prevalent conditions. The leadership appointments include Dean J.

Abbott (NYSE: ABT) is introducing the world’s first glucose sport biosensor,i Libre Sense Glucose Sport Biosensor, which is designed for athletes to continuously measure glucose to better understand the correlation between their glucose levels and their athletic performance.

ArcherDX, Inc. today announced that Jason Myers, Ph.D., Chief Executive Officer and co-founder of ArcherDX, will participate in a fireside chat at Cowen’s 2020 Liquid Biopsy Summit at 2:00 p.m. Eastern Daylight Time (EDT) / 12:00 p.m. Mountain Daylight Time (MDT).

Premier Rx becomes the first national wholesale distributor of independently batch-certified generic medications [17-September-2020] NEW HAVEN, Conn. and WEST CHESTER, Ohio , Sept. 17, 2020 /PRNewswire/ -- Valisure, an online pharmacy attached to an analytical laboratory that chemically certifies every medication it sells, and Premier Rx, an independent pharmaceutic

Flu vaccination is especially important for people who are most at risk of flu complications, namely the 200 million people over the age of 50 and individuals who have chronic health conditions